Tata India Pharma & Healthcare Fund vs DSP Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High Risk |
Asset Size (Cr) | ₹1208 Cr | ₹3198 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹100 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 28 Dec 2015 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 18% |
Expense Ratio | 2.14 | 1.9 |
Manager | Meeta Shetty | Jay Kothari |
ISIN Code | INF277K016A9 | INF740KA1LD8 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | -7.82% | -6.61% |
6 Month | -8.67% | -0.59% |
1 Year | 8.93% | 15.26% |
3 Year | 18.99% | 21.12% |
5 Year | 22.08% | 25.01% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | - | - |
1 Year | 1.05% | 5.87% |
3 Year | 22.81% | 25.18% |
5 Year | 19.82% | 21.74% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 7.82% | 28.82% |
3 Year | 17.79% | 20.72% |
5 Year | 14.55% | 27.72% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 15.471% | 15.136% |
Sharp | 0.874% | 0.954% |
Beta | 0.953% | 0.893% |
Alpha | 0.602% | 2.305% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Meeta Shetty | Jay Kothari |
Total AUM | ₹17847 Cr | ₹0 Cr |
Fund Manage | 5 | 20 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 5.39 | 17.61 |
Small Cap | 23.46 | 41.87 |
Large Cap | 40.33 | 22.07 |
Mid Cap | 30.82 | 18.45 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 5.39 | 17.61 |
Pharmaceuticals & Biotechnology | 76.28 | 68.54 |
Healthcare Services | 14.31 | 11.97 |
Fertilizers & Agrochemicals | 0.83 | - |
Chemicals & Petrochemicals | 0.39 | - |
Insurance | 2.14 | 1.47 |
Retailing | 0.66 | 0.41 |
Top Comparisons
NIPPON INDIA MONTHLY INTERVAL FUND SERIES I REGULAR PLAN GROWTH
3Y Returns5.8%
NIPPON INDIA MONTHLY INTERVAL FUND SERIES I REGULAR PLAN GROWTH
3Y Returns5.8%
HDFC Medium Term Debt Fund - Growth Option
3Y Returns5.99%
SUNDARAM MEDIUM DURATION FUND Regular Plan - Growth
3Y Returns4.28%
Kotak Gold Fund Growth
3Y Returns18.21%
HDFC Gold ETF Fund of Fund - Growth Option
3Y Returns18.51%
HDFC Mid-Cap Opportunities Fund - Growth Plan
3Y Returns24.16%
Quant Mid Cap Fund-Growth
3Y Returns19.55%